Qube Research & Technologies Ltd - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 92 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$138,414
-65.3%
121,416
-72.2%
0.00%
-100.0%
Q2 2023$399,186
+4557.4%
436,269
+2836.8%
0.00%
Q4 2022$8,571
-87.0%
14,855
-92.9%
0.00%
Q3 2022$66,000
-68.7%
209,755
-64.9%
0.00%
-100.0%
Q2 2022$211,000
+33.5%
598,379
+1339.7%
0.00%0.0%
Q2 2021$158,000
-46.3%
41,564
+92.3%
0.00%
-50.0%
Q2 2020$294,00021,6160.00%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 4,652,561$3,340,0005.66%
Orchard Capital Management, LLC 1,762,731$1,265,0000.36%
Ikarian Capital, LLC 1,200,000$860,0000.11%
Ikarian Capital, LLC 800,000$575,0000.08%
XTX Topco Ltd 102,392$74,0000.03%
Nantahala Capital Management 965,800$693,0000.03%
Worth Venture Partners, LLC 63,500$46,0000.02%
Ardent Capital Management, Inc. 43,429$31,0000.02%
Virtus ETF Advisers LLC 65,149$47,0000.02%
RICE HALL JAMES & ASSOCIATES, LLC 513,292$368,0000.02%
View complete list of AKEBIA THERAPEUTICS INC shareholders